Back
Xeris Biopharma Holdings Stock Price Chart
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Buy
56
XERS
Xeris Biopharma Holdings
Last Price:
1.76
Seasonality Move:
-5.66%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XERS is experiencing slight selling pressure.
Xeris Biopharma Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.75 | Sell |
| 20-day SMA: | 1.87 | Sell |
| 50-day SMA: | 2.26 | Sell |
| 200-day SMA: | 2.19 | Sell |
| 8-day EMA: | 1.77 | Sell |
| 20-day EMA: | 1.87 | Sell |
| 50-day EMA: | 2.1 | Sell |
| 200-day EMA: | 2.19 | Sell |
Xeris Biopharma Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 31.88 | Sell |
| Chaikin Money Flow: | -201500 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.77 - 2.07) | Sell |
| Bollinger Bands (100): | (1.93 - 2.77) | Sell |
Xeris Biopharma Holdings Technical Analysis
| Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Xeris Biopharma Holdings Stock
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 1.75 while XERS 8-day simple moving average is 1.75, which is a Sell signal.
- The stock price of XERS is 1.75 while Xeris Biopharma Holdings 20-day SMA is 1.87, which makes it a Sell.
- Xeris Biopharma Holdings 50-day simple moving average is 2.26 while XERS share price is 1.75, making it a Sell technically.
- XERS stock price is 1.75 and Xeris Biopharma Holdings 200-day simple moving average is 2.19, creating a Sell signal.
XERS Technical Analysis vs Fundamental Analysis
Buy
56
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy or a Sell?
-
Xeris Biopharma Holdings stock is rated a Buy
The current Xeris Biopharma Holdings [XERS] share price is $1.75. The Score for XERS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Xeris Biopharma Holdings Stock Info
Market Cap:
259.44M
Price in USD:
1.75
Share Volume:
806K
Xeris Biopharma Holdings 52-Week Range
52-Week High:
3.26
52-Week Low:
1.46
Buy
56
Xeris Biopharma Holdings (XERS)
is a Buy
Xeris Biopharma Holdings Share Price Forecast
-
What is the Xeris Biopharma Holdings stock price today?
The Xeris Biopharma Holdings stock price is 1.75 USD today. -
Will XERS stock go up or go down?
Xeris Biopharma Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Xeris Biopharma Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Xeris Biopharma Holdings is not overvalued.
Is Xeris Biopharma Holdings Stock a Buy?
- Xeris Biopharma Holdings share price is 1.75 while XERS 8-day exponential moving average is 1.77, which is a Sell signal.
- The stock price of XERS is 1.75 while Xeris Biopharma Holdings 20-day EMA is 1.87, which makes it a Sell.
- Xeris Biopharma Holdings 50-day exponential moving average is 2.10 while XERS share price is 1.75, making it a Sell technically.
- XERS stock price is 1.75 and Xeris Biopharma Holdings 200-day simple moving average is 2.19, creating a Sell signal.
Fundamental Analysis of Xeris Biopharma Holdings
Is Xeris Biopharma Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Technical Analysis of Xeris Biopharma Holdings
Should I short Xeris Biopharma Holdings stock?
- XERS Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Xeris Biopharma Holdings is a Sell
- Xeris Biopharma Holdings Relative Strength Index (RSI) is 31.88, which suggest Xeris Biopharma Holdings is oversold
- The Bollinger Bands (25) for Xeris Biopharma Holdings is (1.77 - 2.07), which suggest Xeris Biopharma Holdings is a Sell
- The Bollinger Bands (100) for Xeris Biopharma Holdings is (1.93 - 2.77), which suggest Xeris Biopharma Holdings is a Sell
* Xeris Biopharma Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.